According to Denise Grady in the New York Times, “The pandemic has infected more than 53 million people around the world so far. U.S. cases are soaring, setting records every day. There have been more than 11 million cases and 246,000 deaths. Covid-19 is killing more than 1,100 Americans a day, and the last million cases occurred in just six days.”

Yet there is the promise of hope in news from Moderna including reporting a longer life on the refrigeration shelf and at room temperature but that’s only part of the logistic challenge.  Ensuring no tampering has taken place is crucial to patients’ health, the reputation of all parties involved and their lucrative brands.  Brand protection falls below human safety, but both can be protected with the reassurance of the chain of custody without breaches or tampering.  That’s where OpticalLock enters the picture.  Applying the patented, IoT technology to monitor, track, ensure security, and alert status changes including temperature, humidity, location, and access control drastically improves the packaging and transportation process.  Once the vaccines arrive at their intended location for distribution to patients, the OpticalLock technology secures them while being stored and alerts if any unauthorized personnel tries to access the life saving drugs. 

“An additional concern is that both vaccines must be stored and transported at low temperatures — minus 4 degrees Fahrenheit for Moderna, and minus 94 Fahrenheit for Pfizer — which could complicate their distribution, particularly to low-income areas in hot climates. Although both vaccines are made of mRNA, their temperature requirements differ because they use different, proprietary formulations of fat to encase and protect the mRNA, Ray Jordan, a Moderna spokesman, said.”  The encasement companies who are developing internal temperature-controlled packaging for vaccine distribution can look to OpticalLock to report on external temperatures that may put the vaccines at risk. 

A vaccine on its own will not end the pandemic.” Dr. Tedros Adhanom Ghebreyesus, Head of the WHO.  Despite that reality check, a vaccine for the most at-risk including healthcare workers and the elderly, is a step in the right direction.

OpticalLock has soon-to-be-released product that can protect the vaccines and other high-value items while en route to consumers who require accessing vaccinations at home or other remote locations.  Stay tuned for the continuance of IoT technology making lives betters and providing peace of mind knowing authentic goods arrive at their intended locations without tampering or counterfeiting.

OpticalLock was created to offer peace of mind, safety, and security for high-value assets.  There is no higher value asset than life itself.  Stay safe.  Wear a mask.  We’ll get through this together.

Other Posts

OpticalLock Named Supply & Demand Chain Executive’s 2021 Top 100 Supply Chain Projects

San Diego, California June 28, 2021 – Supply & Demand Chain Executive, the only publication covering the entire global supply chain, selected OpticalLock as a recipient of the Top Supply Chain Projects Award for 2021. The Top Supply Chain Projects (formerly known as SDCE 100) spotlights successful and innovative transformation projects that deliver bottom-line value […]

Read More


Theft is on the rise once again and small business owners are suffering significant financial loss that could have been avoided if they invested in the OpticalLock Secure Monitoring System.  According to Supply Chain Digest, warehouses continue to be the target of significant theft.  In Texas, one distributor, GoTrax, experienced a $600,000 loss in one […]

Read More